Larimar Therapeutics, Inc. LRMR
NASDAQ · United States · Health Technology
$2.96-0.10 (-3.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.30 | -0.38 | +21.4% | $0 | — | +3.0%$3.98→$4.10 |
| Q1 2026 | 2026-05-14 | -0.31 | -0.59 | +47.5% | — | — | -12.7%$4.10→$3.58 |
| Q4 2025 | 2026-03-19 | -0.73 | -0.55 | -32.7% | — | — | +4.4%$4.30→$4.49 |
| Q3 2025 | 2025-11-05 | -0.61 | -0.39 | -56.4% | — | — | -8.7%$3.80→$3.47 |
| Q2 2025 | 2025-08-14 | -0.41 | -0.49 | +16.3% | — | — | — |
| Q4 2024 | 2025-03-24 | -0.45 | -0.32 | -40.6% | — | — | — |
| Q4 2023 | 2024-03-14 | -0.29 | -0.25 | -16.0% | — | — | — |
| Q3 2023 | 2023-11-14 | -0.21 | -0.23 | +8.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.